Novartis Ag ADR (NVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 51,722,000 | 46,660,000 | 43,461,000 | 52,877,000 | 49,898,000 |
| Cost of Goods | 12,827,000 | 12,472,000 | 11,582,000 | 15,867,000 | 15,121,000 |
| Gross Profit | 38,895,000 | 34,188,000 | 31,879,000 | 37,010,000 | 34,777,000 |
| Operating Expenses | 24,351,000 | 24,419,000 | 23,933,000 | 25,321,000 | 24,625,000 |
| Operating Income | 14,544,000 | 9,769,000 | 7,946,000 | 11,689,000 | 10,152,000 |
| Interest Expense | 1,006,000 | 855,000 | 800,000 | 811,000 | 869,000 |
| Other Income | 102,000 | 209,000 | 31,000 | 15,259,000 | 595,000 |
| Pre-tax Income | 13,640,000 | 9,123,000 | 7,177,000 | 26,137,000 | 9,878,000 |
| Income Tax | 1,701,000 | 551,000 | 1,128,000 | 2,119,000 | 1,807,000 |
| Net Income Continuous | 11,939,000 | 8,572,000 | 6,049,000 | 24,018,000 | 8,071,000 |
| Net Income Discontinuous | N/A | 6,282,000 | 906,000 | N/A | N/A |
| Minority Interests | -2,000 | 4,000 | 0 | -3,000 | -1,000 |
| Net Income | $11,941,000 | $14,850,000 | $6,955,000 | $24,021,000 | $8,072,000 |
| EPS Basic Total Ops | 5.92 | 7.15 | 3.19 | 10.71 | 3.55 |
| EPS Basic Continuous Ops | 5.92 | 4.13 | 2.77 | 10.71 | 3.54 |
| EPS Basic Discontinuous Ops | N/A | 3.02 | 0.42 | N/A | N/A |
| EPS Diluted Total Ops | 5.87 | 7.10 | 3.17 | 10.63 | 3.52 |
| EPS Diluted Continuous Ops | 5.87 | 4.10 | 2.75 | 10.63 | 3.52 |
| EPS Diluted Discontinuous Ops | N/A | 3.00 | 0.41 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | 7.81 | 6.90 | 6.10 | 6.24 | 5.75 |
| EBITDA(a) | $20,658,000 | $18,152,000 | $14,911,000 | $11,689,000 | $16,281,000 |